JPMorgan Chase & Co. began coverage on shares of Livongo Health (NASDAQ:LVGO) in a research report sent to investors on Monday, BenzingaRatingsTable reports. The firm issued an overweight rating and a $43.00 price target on the stock.

A number of other brokerages have also recently issued reports on LVGO. Leerink Swann started coverage on Livongo Health in a report on Monday. They issued an outperform rating and a $50.00 target price on the stock. KeyCorp started coverage on Livongo Health in a report on Monday. They issued an overweight rating and a $46.00 target price on the stock. Piper Jaffray Companies started coverage on Livongo Health in a report on Monday. They issued an overweight rating and a $40.00 target price on the stock. Goldman Sachs Group started coverage on Livongo Health in a report on Monday. They issued a buy rating and a $43.00 target price on the stock. Finally, Needham & Company LLC started coverage on Livongo Health in a report on Monday. They issued a buy rating and a $42.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $44.20.

Shares of LVGO opened at $35.42 on Monday. Livongo Health has a 12-month low of $31.60 and a 12-month high of $45.68.

In related news, major shareholder Ab (Publ) Kinnevik acquired 3,141,795 shares of the company’s stock in a transaction on Monday, July 29th. The shares were acquired at an average cost of $28.00 per share, for a total transaction of $87,970,260.00. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, Director Hemant Taneja acquired 2,678,571 shares of the company’s stock in a transaction on Monday, July 29th. The shares were bought at an average price of $28.00 per share, for a total transaction of $74,999,988.00. The disclosure for this purchase can be found here.

Livongo Health Company Profile

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Recommended Story: What does a hold rating mean?

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.